Go to the reading

A question to work through

What is MOTS-c, in plain words?

A name for a substance in the body. A different question when it is offered as treatment.

The name can sound like something you are expected to know. You do not need to learn its long scientific name to ask a useful question about care.

A small chain

MOTS-c belongs to a group called peptides: short chains made from protein building blocks.

Its chain has 16 building blocks. A

The recipe for it sits in mitochondria, the tiny parts of cells that help supply energy.

Your body already makes it

Researchers have found the body's own MOTS-c in human blood and muscle. A

Measuring what the body makes does not tell us what an injected product would do. B

Natural does not settle the question

The FDA reviews US medicines. In its review checked September 30, 2026, the possible harms of giving MOTS-c to people remained unknown. B

If an offer says MOTS-c is natural, ask what happened when people received the exact product being offered. Ask whether that product was tested at all.

See which questions about harm remain open

Bring the conversation back to your goal

Try naming the concern before naming a substance. Are you asking about weight, energy or something else? Let the clinician hear that concern in your words.

Then ask what evidence applies to that concern. A description of how a substance might work is not an answer about what a treatment has achieved.

Carry this with you

Remember the distinction: a substance found in the body and a tested treatment are separate things.

Follow the evidence, one kind at a time

Source notes for this page

A. Lee and colleagues' original research

The paper describes MOTS-c and reports animal research. The FDA review also describes measuring the body's own MOTS-c in people.

B. FDA's assessment of the missing evidence

The FDA review describes laboratory work. Those findings do not tell us whether giving MOTS-c to people helps them or harms them.